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BACKGROUND: As many as 80% of patients with asthma suffer from allergic rhinitis (AR), and
rhinitis symptoms are associated with sleep complaints The aim of this cross-sectional study was to
assess the prevalence of obstructive sleep apnea syndrome risk in patients with asthma and to
explore the association between comorbid rhinitis and obstructive sleep apnea syndrome risk.
METHODS: Subjects with asthma were recruited by general practitioners during a control visit.
Physicians compiled a questionnaire that assessed the presence of AR according to ARIA (Allergic
Rhinitis and Its Impact on Asthma) guidelines and factors influencing the risk of obstructive sleep
apnea syndrome (gastroesophageal reflux disease, obesity, smoking). Subjects completed a ques-
tionnaire evaluating the presence and severity of AR and the STOP-BANG questionnaire (snoring,
tiredness during daytime, observed apnea, high blood pressure, body mass index, age, neck cir-
cumference, gender), a validated screening method to identify obstructive sleep apnea syndrome
risk. Physicians were blinded to the subjects’ questionnaires, ensuring objectivity of the method.
RESULTS: The analyses were conducted on 1,941 subjects (males 58%, mean age 48.2  15.2 y):
740 with asthma alone and 1,201 with asthma and AR. STOP-BANG revealed that 52.6% of the
subjects were at increased risk of obstructive sleep apnea syndrome: 47.3% of subjects with asthma
alone and 55.9% of patients with asthma and AR. Rhinitis was associated with a 1.44 times higher
odds ratio for having obstructive sleep apnea syndrome risk. Rhinitis duration and severity were
associated with obstructive sleep apnea syndrome risk, although the latter deserved greater im-
portance. The results showed that, once a correction for each of these factors was performed,
subjects with AR with an odds ratio of 1.99 were reported to be at risk of obstructive sleep apnea
syndrome. CONCLUSIONS: The probable increased risk of obstructive sleep apnea syndrome is
associated with the concomitant presence of rhinitis, independent of obesity and other contributors
to risk of obstructive sleep apnea syndrome. Key words: asthma; allergic rhinitis; obstructive sleep
apnea syndrome; risk; sleep apnea; STOP-BANG. [Respir Care 2014;59(12):1851–1856. © 2014 Daeda-
lus Enterprises]
Introduction
Almost 80% of patients with asthma suffer from comor-
bid rhinitis,1 and rhinitis symptoms are associated with
sleep complaints.2 Furthermore, rhinitis could be consid-
ered a risk factor for sleep-disordered breathing3 on the
basis of physical laws: the Bernoulli principle states that
the wider the beginning of the airway, the less the risk of
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collapse; the narrower the beginning, the greater the risk of
risk of collapse. Moreover, the Venturi effect states that air
must pass through a small tube faster than through a large
tube if the passing volume of air and time are equal. There-
fore, the upper airways behave like a Starling resistor: the
obstruction at the inlet (ie, the nasal airway) produces
collapsing forces that manifest downstream in the collaps-
ible segment, the pharynx.4 Clinical observations have
shown that patients who report nasal congestion due to
allergic rhinitis (AR) are significantly more likely to be
habitual snorers and have an increased risk of sleep-dis-
ordered breathing.3,5 In addition, apneas are longer and
more frequent in patients with nasal congestion than in
patients without,6 and this phenomenon seems to be strictly
related to the cross-sectional area of upper airways.7 AR
therefore seems involved in snoring, apnea, and hypopnea
pathogenesis and can further worsen symptoms of obstruc-
tive sleep apnea syndrome.8 It has been shown that pa-
tients with obstructive sleep apnea syndrome with con-
comitant AR have significantly higher fatigue, daytime
sleepiness, and stress compared with patients with obstruc-
tive sleep apnea syndrome without AR.9 Cross-section-
al10-13 and longitudinal14 studies found that asthma is as-
sociated with both the clinical features of obstructive sleep
apnea syndrome11,12,14 and diagnosis of obstructive sleep
apnea syndrome established by polysomnography.10,13 Bi-
directional influences probably exist between the 2 condi-
tions, and obstructive sleep apnea appears to affect asthma
control.
Obstructive sleep apnea syndrome was found to be a
risk factor for frequent asthma exacerbations in a large
population of difficult-to-control patients with asthma.15
Additionally, in a cross-sectional survey, obstructive sleep
apnea syndrome risk was associated with poorly controlled
asthma; indeed, asthmatic patients at high risk of obstruc-
tive sleep apnea syndrome have a 3.6 odds ratio to have
poorly controlled asthma. Other factors such as obesity,
black race, nasal disorders, gastroesophageal reflux dis-
ease, and psychiatric diseases are also associated with
greater risk of uncontrolled asthma. Nevertheless, multi-
variate stepwise logistic regression models of uncontrolled
patients (also adjusted for the above-mentioned factors)
showed that patients with increased obstructive sleep ap-
nea syndrome risk and maintaining an odds ratio of 2.87
are poorly controlled.16 More recent evidence showed that
obstructive sleep apnea syndrome risk is associated with
persistent daytime asthma symptoms to an extent that
matched or exceeded associations with nighttime asthma
symptoms.17 In other words, obstructive sleep apnea syn-
drome is a potential contributor to overall asthma control
on a much larger scale and is independent of the other
known variables. In summary, AR may worsen obstructive
sleep apnea syndrome, and this can negatively influence
asthma control. Despite these concerns, there is still a
shortage of studies on the association of rhinitis with sleep
apnea risk in patients with asthma. The available knowl-
edge is based on the observation of patients with rhinitis
and of patients with asthma, whereas no data are available
on patients with asthma and comorbid rhinitis. Further-
more, the data on asthma are focused mainly on the effect
of obstructive sleep apnea syndrome on disease control,
rather than the association between asthma and obstructive
sleep apnea syndrome. In addition to the role of obesity,
several mechanisms such as overnight increase in para-
sympathetic tone, nonadrenergic noncholinergic system
modulation, and airway inflammation could trigger apnea
onset.8 The aim of this cross-sectional study was to assess
the prevalence of obstructive sleep apnea syndrome risk in
subjects with asthma with or without comorbid rhinitis and
to explore the association between rhinitis duration and
severity and obstructive sleep apnea syndrome risk.
Methods
A quantitative research program using a questionnaire
data collection method was performed; the study design
was based on the subjects’ recruitment by physicians. The
study population included adult subjects with asthma di-
agnosed by a physician, according to Global Initiative for
Asthma18 guidelines, while attending a general practitio-
ner’s office for scheduled visits. Subjects attending the
office for an unscheduled asthma visit, pregnant women,
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Up to 80% of patients with asthma suffer from allergic
rhinitis, which is associated with complaints of sleep
disturbances and fatigue. The prevalence of obstructive
sleep apnea syndrome in patients with asthma and co-
morbid rhinitis has not been completely elucidated.
What this paper contributes to our knowledge
There was an association of increased risk of obstruc-
tive sleep apnea syndrome and concomitant presence of
rhinitis, independent of obesity and other contributors
to risk of obstructive sleep apnea syndrome.
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and patients with COPD were excluded, but smokers were
not.19 This study was performed according to good clinical
practice standards and the Declaration of Helsinki and was
approved by the local ethics committee.
Once written informed consent was obtained, physi-
cians completed a questionnaire consisting of 5 multiple
choice questions aimed at assessing the presence of rhini-
tis and other factors that could influence the risk of ob-
structive sleep apnea syndrome (ie, gastroesophageal re-
flux disease, obesity, smoking). Moreover, physicians were
asked to indicate whether, according to their point to view,
the subject could suffer from obstructive sleep apnea syn-
drome. Physicians had to provide the classification of se-
verity according to ARIA (Allergic Rhinitis and Its Impact
on Asthma) guidelines for subjects suffering from rhini-
tis.19 Subjects were asked to answer a questionnaire in-
cluding questions about personal characteristics (age, sex,
height, weight), presence of 2 or more rhinitis symptoms
and their frequency and severity apart from colds, and the
presence and frequency of nocturnal awakenings caused
by asthma or rhinitis according to ARIA classification.20
Moreover, subjects were asked to respond to the STOP-
BANG questionnaire, a validated screening method to iden-
tify individuals at risk of obstructive sleep apnea.21 STOP-
BANG is composed of 8 yes/no questions based upon
snoring, tiredness/sleepiness, observed apneas, hyperten-
sion, body mass index  35 kg/m2, age  50 y, neck
circumference  40 cm, and male gender. A score of 3 or
more positive responses is considered increased risk for
obstructive sleep apnea syndrome. In fact, a score of  3
has shown a high sensitivity for detecting obstructive sleep
apnea (93 and 100% for moderate and severe obstructive
sleep apnea, respectively),22 and a score of 5–8 has iden-
tified patients with high probability of moderate/severe
obstructive sleep apnea.23 Farney et al24 showed that a
score of  3 has a 85.1% probability to identify subjects
with obstructive sleep apnea.
Physicians were blinded to the subjects’ questionnaires,
ensuring objectivity of the method. Because of the obser-
vational nature of the study and because the survey was
performed in a general practitioner’s office, it was estab-
lished a priori that only subjects for whom rhinitis had
been reported by both themselves and the physician in a
blinded setting were included.
The study was conducted between March and Decem-
ber 2011 in all Italian regions, and 1,700 general practi-
tioners participating in a continuing medical educational
program were involved. In particular, general practitioners
were asked to enroll a maximum of 5 consecutive patients
with asthma. The recruitment of 3,500 patients with asthma
was considered sufficient to explore the study aim. Sample
size was estimated considering a 10% data failure in sub-
jects’ and physicians’ questionnaire fulfillment, the prev-
alence of rhinitis in asthma,20 an estimated 60% concor-
dance of subjects and physicians in defining concomitant
rhinitis presence or absence, and an estimated STOP-
BANG-defined increased obstructive sleep apnea risk of
27.5%.25
Statistical Analysis
Analyses were conducted on data from subjects with
asthma with or without comorbid rhinitis identified by
both physicians and subjects. Baseline variables were sum-
marized as the mean  SD for continuous variables and
percentiles for categorical variables. A univariate logistic
regression model was conducted to test for relationships of
increased risk of obstructive sleep apnea syndrome (STOP-
BANG score  3) with rhinitis classification according to
ARIA guidelines. Multivariate logistic regression models
were then performed in subjects with increased risk of
obstructive sleep apnea syndrome (defined based on STOP-
BANG) as the outcome, with stepwise adjustment for fac-
tors known to worsen sleep apnea. The aforementioned
covariates (P  .05) indicate statistical significance. Anal-
yses were performed using statistical software (SPSS 20,
SPSS, Chicago, Illinois).
Results
Among the 1,700 physicians participating in the con-
tinuing medical educational program, 1,678 completed the
questionnaire and enrolled at least 2 subjects each. A total
of 3,527 subjects who provided informed consent and com-
pleted the questionnaire were reached, from an invited
population of 3,950.
Fifty-three subjects were subsequently excluded due to
incomplete questionnaires, and the analyses were reduced
to a sample of 3,474 subjects. Subjects were considered
for the analysis only if their report of presence or absence
of concomitant rhinitis was in accordance with the physi-
cian’s report. The analyses were therefore reduced to a
sample of 1,941 subjects: 740 with asthma alone and 1,201
with asthma and comorbid rhinitis. Clinical and demo-
graphic data are reported in Table 1.
The majority of the subjects (75.27%) reported at least
one nocturnal awakening related to a breathing disorder
during the month before, of which 40.6% had 3 or more
awakenings per week.
According to the STOP-BANG questionnaire, 1,020
(52.6%) subjects were classified as being at increased risk
of obstructive sleep apnea syndrome: 350 of 740 (47.3%)
subjects with asthma alone and 670 of 1,021 (55.9%) sub-
jects with asthma and comorbid rhinitis. Subjects’ responses
to the STOP-BANG questionnaire are reported in Table 2.
SLEEP APNEA RISK IN SUBJECTS WITH ASTHMA
RESPIRATORY CARE • DECEMBER 2014 VOL 59 NO 12 1853
Association Between Rhinitis and Risk of Obstructive
Sleep Apnea Syndrome
In univariate analyses, rhinitis was associated with a
1.44 times higher odds ratio for having increased obstruc-
tive sleep apnea syndrome risk (defined according to STOP-
BANG). Body mass index  30 kg/m2, sex, age, and smok-
ing were also associated with an increased odds ratio for
obstructive sleep apnea syndrome risk, whereas gastro-
esophageal reflux disease was not (Table 3).
A multivariate logistic regression model was performed
to assess the presence of an increased risk of obstructive
sleep apnea syndrome, taking into account factors that
typically worsen obstructive sleep apnea syndrome. The
results showed that, once a correction for each of these
factors was performed, subjects with AR with an odds
ratio of 1.99 were reported to be at risk of obstructive sleep
apnea syndrome (Table 4).
Discussion
Data from a large sample of subjects with asthma showed
that increased risk of obstructive sleep apnea syndrome is
associated with the concomitant presence of rhinitis. This
relationship emerged independently of obesity and other
contributors to risk of obstructive sleep apnea syndrome.
Although this cross-sectional study cannot prove causal
relationships, our data and analyses support available ev-
idence for the relationship between obstructive sleep ap-
nea syndrome and rhinitis. This finding further emphasizes
the clinical problem in a cohort of subjects, such as pa-
tients with asthma, in which the prevalence of rhinitis is
very high. Rhinitis is a well-known asthma trigger, but
also could be involved in the pathogenesis of sleep breath-
ing disorders, such as obstructive sleep apnea syndrome.
Table 1. Demographic and Clinical Data
Characteristics Values
Male, % 58
Age, mean  SD, y 48.2  15.2
Neck circumference, mean  SD, cm 40.4  2.2
Height, mean  SD, cm 169.3  8.7
Weight, mean  SD, kg 74.6  14.8
BMI, mean  SD, kg/m2 25.9  4.6
Obesity (BMI  30), % 17
Gastroesophageal reflux disease, % 28
Sleep apnea, % 40.55
Active smoker, % 19
Rhinitis, % 61.88
Rhinitis classification*
Mild intermittent, % 35.5
Moderate-severe intermittent, % 16.6
Mild persistent, % 16.6
Moderate-severe persistent, % 31.3
n  1,941
* Rhinitis classification severity is according to ARIA guidelines.19
BMI  body mass index
Table 2. Subjects’ Answers to STOP-BANG Questionnaire
Subjects, n (%)
S Do you snore loudly (louder than talking
or loud enough to be heard through
closed doors)?
965 (50)
T Do you often feel tired, fatigued, or sleepy
during daytime?
1,208 (62)
O Has anyone observed you stop breathing
during sleep?
638 (33)
P Do you have or are you being treated for
high blood pressure?
694 (36)
B BMI  35? 82 (4)
A Age  50 y? 816 (42)
N Neck circumference  40 cm? 642 (44)
G Gender, male? 1,111 (58)
n  1,941
BMI  body mass index
Table 3. Univariate Associations of High Obstructive Sleep Apnea
Risk With Characteristics Known to Predict Obstructive
Sleep Apnea
Characteristics Odds Ratio (95% CI) P
Obesity (BMI  30) 5.81 (4.27–7.92)  .001
Gender (male vs female) 7.8 (6.4–9.7)  .001
Age (class of 5 y) 1.42 (1.37–1.48)  .001
Gastroesophageal reflux disease 1.18 (0.97–1.44) .10
Smoker 3.15 (2.4–4.1)  .001
Rhinitis 1.44 (1.17–1.69)  .001
Defined on the basis of the STOP-BANG questionnaire.
BMI  body mass index
Table 4. Multivariate Logistic Regression Models of Increased
Obstructive Sleep Apnea Risk With Adjustment for Factors
Known to Worsen Sleep Apnea
Odds Ratio (95% CI) P
Age, y 1.08 (1.07–1.09)  .001
Gender (male vs female) 8.97 (7.42–10.86)  .001
Obesity (BMI  30) 3.77 (2.82–5.04)  .001
Gastroesophageal reflux disease 1.04 (0.85–1.27) .70
Smoker 2.59 (2.04–3.30)  .001
Rhinitis 1.37 (1.14–1.64)  .001
Defined on the basis of the STOP-BANG questionnaire.
BMI  body mass index
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Based on analysis of a large population sample, according
to the STOP-BANG score, subjects with comorbid rhinitis
exhibit an increased risk of obstructive sleep apnea syn-
drome (odd ratios of 1.37) compared with those subjects
without it. A multivariate logistic regression model of in-
creased risk of obstructive sleep apnea with adjustment for
well-known worsening factors of sleep apnea confirmed
that when age, sex, smoking, obesity, and gastroesopha-
geal reflux disease were sequentially excluded, rhinitis
remained associated with an increased risk of obstructive
sleep apnea syndrome. These results suggest an intriguing
relationship between rhinitis and obstructive sleep apnea
syndrome. However, they need to be further confirmed
using a well-defined population of patients with asthma
and with obstructive sleep apnea syndrome diagnosis con-
firmed or excluded by polysomnography.
As our data suggest, there is a likely substantial bur-
den of unrecognized and untreated obstructive sleep ap-
nea in patients with asthma. This is a population that
could benefit considerably from having their sleep dis-
order addressed, as other data and analyses have also
described.26,27
Limitations of our study include the use of a question-
naire-based approach since polysomnography seemed to
be prohibitively expensive for this cross-sectional study
given the sample size and subjects’ recruitment setting.
However, in a large sample of sleep subjects, the STOP-
BANG method demonstrated high internal validity and
good sensitivity.25 Furthermore, this instrument has high
diagnostic value in comparison with other sleep apnea
screening instruments.21
Conclusions
In summary, this study shows that rhinitis is associated
with the probable increased risk of obstructive sleep apnea
syndrome in patients with asthma. Clinicians should con-
sider rhinitis as a potential reason for poor asthma control,
but also as an associated factor of obstructive sleep apnea
syndrome, which is a cause itself of increased asthma
symptoms. Prospective studies with objective sleep and
airway assessment of these putative mechanistic links are
recommended to enhance understanding and identify means
to intervene in asthma with comorbid rhinitis and obstruc-
tive sleep apnea syndrome.
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